Susquehanna analyst Pablo Zuanic said he expects Monster Beverage (MNST) to provide good guidance commentary, but he is concerned about margin pressures and lower overseas growth. He does not think the U.S. growth rate is sustainable and also does not believe regulatory risk is priced in, nor is continued margin pressure. Zuanic also said he does not see a bid from Coca-Cola (KO). Zuanic reiterated his Negative rating and lowered his price target to $54 from $56 on Monster Beverage shares.

Truist downgraded Monster Beverage to Sell from Buy with a price target of $46, down from $65.

JPMorgan analyst Andrea Teixeira downgraded Monster Beverage to Neutral from Overweight with a price target of $59, down from $66, ahead of the company's Q1 earnings report on May 8. While the shares have already sold off, there are limited catalysts to the upside at this point as "long-hoped for potential price increases somehow lost their attractiveness" due to the latest run up in aluminum prices and an already-stretched lower income consumer, the analyst tells investors in a research note. Moreover, the firm says Monster's tracked and untracked channel trends are still challenged and it appears that household penetration and buy rates are pressured.

Latest data shows the largest indicative borrow rate increases among liquid option names include: Luminar Technologies (LAZR) 21.68% +6.44, Mesoblast (MESO) 145.03% +2.00, iShares S&P National AMT Free Municipal Bond Fund (MUB) 19.65% +1.21, Stellantis NV (STLA) 1.41% +0.98, Veritone (VERI) 40.08% +0.46, ALTC Acquistion Corp (ALCC) 6.05% +0.44, US Global Jets ETF (JETS) 7.23% +0.36, Nokia (NOK) 3.33% +0.27, Annovis Bio Inc (ANVS) 91.57% +0.16, and Coca Cola (KO) 0.41% +0.16.